Chinese gene therapy company Gritgen Therapeutics has announced the launch of operations at its commercial GMP facility in Suzhou Industrial Park. 18 October 2023
India’s Sun Pharmaceutical Industries has presented Phase IV data on its Cequa (cyclosporine ophthalmic solution) showing sustained improvement in dry eye disea 12 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.